Teva first to launch generic Axert

13-07-2015

Teva first to launch generic Axert

Pharmaceutical company Teva has become the first business to launch a generic version of Janssen Pharmaceuticals’s migraine treatment drug Axert (almotriptan malate).


Janssen, Teva, Axert, patent, ANDA, FDA

LSIPR